Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Alembic Pharmaceuticals Limited
Press Release Apr 25 2022
Business
Apr 25 2022
3 min read

Press Release Apr 25 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 25-Apr-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Clobetasol Propionate Foam, 0.05%

View Attachment